Please Wait
Applying Filters...
menu
    • menu
    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Your reliable CDMO partner - agile, scalable, top-quality Small Molecule API & HPAPI solutions from concept to market

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    NXP900

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nuvectis Hosts KOL on NXP900 Phase 1b Trial in Advanced Tumors
    Nuvectis Hosts KOL on NXP900 Phase 1b Trial in Advanced Tumors

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194268/0/en/Nuvectis-Pharma-to-Host-a-Virtual-Key-Opinion-Leader-Meeting-to-Discuss-the-NXP900-Phase-1b-Program-in-Advanced-Solid-Tumors-Including-the-Combination-with-Osimertinib-in-NSCLC.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share
    Nuvectis Pharma Provides Poster Presentation Highlight for NXP900
    Nuvectis Pharma Provides Poster Presentation Highlight for NXP900

    27 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/27/3174533/0/en/Nuvectis-Pharma-Provides-Poster-Presentation-Highlights-for-NXP900-from-the-2025-AACR-NCI-EORTC-International-Conference-on-Molecular-Targets-and-Cancer-Therapeutics.html

    GLOBENEWSWIRE
    27 Oct 2025
    Share Share
    Nuvectis Pharma To Present NXP900 At 2025 Cancer Therapeutics
    Nuvectis Pharma To Present NXP900 At 2025 Cancer Therapeutics

    16 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/16/3167841/0/en/Nuvectis-Pharma-Announces-Upcoming-Presentations-for-NXP900-at-the-2025-AACR-NCI-EORTC-International-Conference-on-Molecular-Targets-and-Cancer-Therapeutics.html

    GLOBENEWSWIRE
    16 Oct 2025
    Share Share